Summary: In order to assess immunity to rubella infection in Dongguan, China, we conducted a seroprevalence survey on rubella and measured rubella-specific IgG in serum samples by ELISA. A total of 1017 individuals aged 0-59 years were selected with a multistage cluster sampling. Among them, 904 (88.9%) were seropositive to rubella. Two groups (20-29 and ≥40 years) had seropositivity rates <90%. Compared to participants age ≥20 years, rubella protection rates were higher in participants aged <20 years (93.7% vs. 83.2%; χ 2 =28.063, p<0.001). Among women aged 20-29 years, only 63.8% had antibodies above the protective level. Multivariate analysis revealed that only sex and age were significantly associated with rubella protective antibody levels. Our results suggest that the women of childbearing age have greater serological susceptibility to rubella in our area. Additional vaccination of susceptible young adults with rubella-containing vaccine should be considered, especially in women before pregnancy.
Introduction
Rubella is a mild self-limiting infectious disease that mainly occurs in children.
However, infection with rubella virus in the first trimester of pregnancy may lead to miscarriage, stillbirth or a child born with congenital rubella syndrome (CRS).
CRS is one of the greatest risks to newborn infants and may entail a variety of birth defects, like sensi-neural deafness, cataract, and cardiac defects (1, 2) A c c e p t e d M a n u s c r i p t Therefore, in 2000, the World Health Organization (WHO) recommended the use of rubella-containing vaccine (RCV) in all national childhood immunization schedules to prevent congenital rubella infection, including CRS (3) . Moreover, goals to eliminate rubella and CRS were established by WHO in America in 2010 and will be proposed in the European and Western Pacific regions in 2015 (4, 5) .
Rubella has been included in the surveillance system in China since 2004. The reported incidence of rubella in China was 9.11 per 100,000 population in 2008 and 5.26 per 100,000 population in 2009. The proportion of rubella cases aged <20 years was 82.54%. In Eastern China (RCV was introduced earlier than in central and western areas), cases aged 15-35 years accounted for 52.35% and 55.60% of the total in the two study years, respectively, and the proportion of cases in this age group was higher than that in central and western areas (6) .
In China, a single dose of rubella vaccine was introduced in 1995, and in 2007 RCV was implemented in the national immunization program with a catch-up campaign targeting children aged 1-14 years (7, 8) In Guangdong province, rubella vaccine was included into the Guangdong Expanded Program of Immunization (EPI) in 2001, but recipients should charge for the vaccine until 2008 (9) . According to the national vaccination program, RCV is planned in children at age 8 months and 18-24 months. Before 2008, the rubella vaccine coverage in 1-year-old children was 50-60% in China (7, 10) .
Serological survey can provide useful information to identify the subpopulation at risk and address possible immunization strategies for rubella. In A c c e p t e d M a n u s c r i p t this study, we collected serum and used ELISA kits to determine rubella antibody (IgG) to evaluate immunity to rubella following implementation of the rubella vaccination program in Dongguan city, Southern Guangdong province, and to assess factors influencing immunity against rubella.
Materials and methods

Study design
A multistage sampling design was used. The 33 towns in Dongguan were stratified into five regions (east, south, central, west and north) to account for geographic variations. One town in each region was sampled and two villages in each town were then selected. A starting household was identified from a list of households in each selected village. Simple random sampling selection was used for the towns, villages and starting households. The house was then examined to determine if anyone of eligible age (0-59 years) was living there. Subsequently, the nearest household to the right was visited and the steps repeated until the desired number of persons (at least 100 participants for each village) was obtained.
Sera were stratified into seven age groups: <2 years, 2-4 years, 5-9 years, 10-19 years, 20-29 years, 30-39 years, and ≥40 years. The formula
was used to calculate the sample size for each age group [11] , which estimated the age-specific seroprevalence as 80-90% [12] , with a precision of 0.1; the calculated sample size was between 42 and 96 in 
Data collection
Each participant was asked to fill out a questionnaire anonymously about personal information such as sex, date of birth, occupation, education status, marital status, residential status (local residents or immigrants, the immigrant were those lived in Dongguan at least 3 months before sampling), and date of sampling. Information regarding the RCV vaccination (routine and campaign) was collected from the China Information Management System for Immunization Programming.
Laboratory assay
Rubella antibody (IgG) was estimated using commercially available ELISA kits 
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value of <10 IU/mL was considered negative.
Statistical analysis
Statistical analysis was performed using SPSS for Windows version 15.0. The total seropositivity rate was calculated by the adjusted sampling weight, and the formula wi=(∑ni) Ci/ni was used to calculate the adjusted sampling weight, where
Ci is the age group proportion, and ni is the sample size in the age group. The age group proportion was based on the data from the 6 th Chinese Population Census.
The associations between rubella antibody positivity and age, sex, occupation, education status, marital status, and residential status were analyzed using the Pearson χ 2 test or χ 2 test with continuity correction. The Kruskal-Wallis H and Mann-Whitney U tests were used for comparisons of rubella antibody titers between groups. Multivariate logistic regression was applied to determine the factors that influenced rubella antibody positivity. Variance inflation factor (VIF) was used to check for multi-colinearity. A p value <0.05 was taken as the level of significance. 
Results
Demographics
Coverage rate of RCV
In the catch-up campaign in 2008, a total of 395 590 eligible children (aged 1-14 years old) were identified in Dongguan and the coverage rate was 100%.
In the birth cohort during November 2007 to October 2011, there were 656 627 eligible children for the first dose of RCV and the coverage rate was 100%.
There were 789 312 eligible children for the second dose of RCV; 456 985 children received the second dose and the coverage rate was only 58.9%.
Prevalence of seropositivity and antibody against rubella
The median rubella antibody titer was 44.36 IU/mL (interquartile range: Seropositivity differed among the age groups (χ 2 =58.078, p<0.001). Education level, occupation and marital status were associated with seropositivity (p<0.001).
There was no significant association between residential status and rubella antibody positivity (p>0.05) ( Table 2) .
Multiple logistic regression models were used to control potential confounders, which showed that compared with people aged 20-29 years, those aged 10-19 years and 30-39 years were 2.82 (95% CI: 1.23，6.48) and 4.37 (95% CI: 1.97，
9.69) times more likely to be seropositive for rubella, respectively. Compared with A c c e p t e d M a n u s c r i p t males, females had lower seropositivity to rubella virus (OR=0.14, 95% CI:
0.08-0.24). VIF was used to check for multi-colinearity. None of the VIF values was up to 5, which meant there was no colinearity in the model (Table 2 ).
Discussion
Our study showed a total seropositivity of 86.2% in the general population in (12, 15) . The results were similar our data, and compared to the pre-vaccine era, the seropositivity in the general population was increased.
In our study, the seropositivity rate was high in people aged <20 years, which Our results were consistent with previous studies in which age was an independent predictor of anti-rubella antibody positivity (16, 17) . As mentioned before, the use of rubella vaccine may result in high positivity in participants aged <20 years. Most participants aged ≥20 years (people born before 2008) acquired immunity from natural infection. Differences in circulation of the virus and epidemics of rubella in the community may explain the positivity variation. In addition, there is evidence that inadequate rubella vaccination coverage (≤80%) may disturb transmission dynamics. As a result, the susceptibility age increases, and susceptibility among women of childbearing age may increase the risk of CRS (18) . It has been reported that the susceptibility age increased after rubella immunization of children in Shandong province (10) . In Dongguan, during 2007-2011, the incidence of rubella was 1.24 per 100,000 population, and the highest proportion of 36.18% of the total cases was in those aged 20-29 years (19) . Routine RCV administration in our area only started in 2008, thus, the effect of the vaccination program should be investigated further, especially the impact on the age-susceptibility pattern. Our current data show that two age groups Similar to previous studies (21), our results showed that women had lower seropositivity rates than men. However, inconsistent results have been reported in previous studies. Some studies have shown that women were more likely to have high seropositivity against rubella (4), and other studies have reported no significant sex difference in seropositivity against rubella (22) . This inconsistency may be partly explained by differences in rubella infection and vaccination histories between study populations.
There were some limitations to the present study. First, few of the participants reported a history of rubella vaccination, and we excluded data of vaccination history in the final analysis. So, we could not identify the effect of vaccination on the seroprevalence of rubella in the population. Second, the number of younger children (<2 years) was relatively small, because the parents (especially those with children <1 year) were unwilling to donate a blood sample from their children.
The number of samples from children aged <1 year was so small that we could not stratify this age group and analyze it independently. Third, the serology results may be biased, because the first and the second sampling stages were not conducted by probability proportionate to size sampling, number of cluster is relatively small, and sampling design was not considered when calculate A c c e p t e d M a n u s c r i p t prevalence.
In conclusion, our study showed that people aged 20-29 and ≥40 years had low rates of rubella seropositivity, especially women. Two doses of RCV have been given routinely to children in our area since 2008. The vaccination may disturb transmission dynamics of the disease, and inadequate vaccination coverage may result in an increase in susceptibility age (18) . Therefore, maintaining high vaccination coverage in children and implementation of sensitive disease surveillance are necessary for controlling the disease and RCV. Women of childbearing age have high serological susceptibility to rubella in our area, which suggests that additional RCV vaccination of susceptible young adults should be considered, especially in women before pregnancy.
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